Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,169
Stocks News & Analysis
stocks
Is SpaceX a threat to this ASX giant?
stocks
Chart of the Week: This ASX top pick might be overlooked
stocks
ASX share undervalued as margins expected to rebound
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,146.20 | 19.70 | -0.21% |
| CAC 40 | 8,430.79 | 16.48 | -0.20% |
| DAX 40 | 24,934.67 | 24.26 | 0.10% |
| Dow JONES (US) | 51,492.55 | 507.12 | -0.98% |
| FTSE 100 | 10,508.61 | 14.40 | 0.14% |
| HKSE | 23,989.17 | 322.99 | -1.33% |
| NASDAQ | 26,021.66 | 354.69 | -1.34% |
| Nikkei 225 | 71,087.66 | 1,185.41 | 1.70% |
| NZX 50 Index | 13,374.20 | 18.78 | -0.14% |
| S&P 500 | 7,420.10 | 91.25 | -1.21% |
| S&P/ASX 200 | 8,927.20 | 21.50 | -0.24% |
| SSE Composite Index | 4,115.28 | 7.21 | 0.18% |